HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)

Diseases existing at birth and often before birth, or that develop during the first month of life (INFANT, NEWBORN, DISEASES), regardless of causation. Of these diseases, those characterized by structural deformities are termed CONGENITAL ABNORMALITIES.
Also Known As:
Congenital Disorders; Congenital Disorder; Disorder, Congenital; Disorders, Congenital; Neonatal Diseases and Abnormalities
Networked: 668 relevant articles (9 outcomes, 21 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Thrombocytopenia (Thrombopenia)
2. Proteinuria
3. Hematuria
4. Hemophilia A (Haemophilia)
5. Aplastic Anemia (Anemia, Hypoplastic)

Experts

1. Freeze, Hudson H: 15 articles (08/2015 - 03/2002)
2. Körner, Christian: 7 articles (01/2012 - 03/2002)
3. Marquardt, Thorsten: 6 articles (12/2015 - 03/2004)
4. Seta, Nathalie: 6 articles (08/2015 - 06/2002)
5. Ng, Bobby G: 6 articles (08/2015 - 04/2013)
6. Pérez, Belén: 5 articles (09/2015 - 02/2009)
7. Pérez-Cerdá, Celia: 5 articles (09/2015 - 02/2009)
8. Matthijs, Gert: 5 articles (04/2014 - 03/2002)
9. Jaeken, J: 5 articles (12/2008 - 01/2000)
10. Dupré, Thierry: 5 articles (05/2005 - 06/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Congenital, Hereditary, and Neonatal Diseases and Abnormalities:
1. Factor VIII (Coagulation Factor VIII)IBA
2. DNA (Deoxyribonucleic Acid)IBA
3. Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
4. EnzymesIBA
01/01/2009 - "Congenital disorders of metabolism show a wide spectrum of symptoms as a consequence of impairment of a certain metabolic pathway by mutated enzymes resulting in abnormal accumulation of enzyme substrates, deficiency of expected products, and abnormal burden to collateral metabolic pathways, etc. However, in some occasions, depending on which pathway up to what degree of disturbance, it can be asymptomatic until a certain kind of burden is placed on to the patient. "
07/01/1992 - "Intrasplenic transplantation of hepatocytes relieved congenital disorders of liver enzymes in rats. "
01/01/1993 - "Emphasis is put on the following aspects: 1) relationship between peroxisomal size and enzyme concentration; 2) abnormal enlargement of peroxisomes in many congenital disorders with peroxisomal dysfunction; 3) normal localization of matrix enzymes in several patients with peroxisomal dysfunction, with the exception of catalase, which is mainly cytoplasmic; 4) ghost-like peroxisomes in the liver of several syndromes but not in nine cases labelled as Zellweger; 5) discrepancies between liver and cultured fibroblasts; 6) trilamellar, regularly spaced inclusions, large stacks of which are birefringent, indicate a peroxisomal dysfunction; their absence does not exclude it. "
01/01/1990 - "An autosomal recessive disorder, congenital adrenal hyperplasia, results from a deficiency in the activity of one of the five enzymes required for cortisol biosynthesis. "
11/01/2007 - "The urea cycle disorders constitute a group of rare congenital disorders caused by a deficiency of the enzymes or transport proteins required to remove ammonia from the body. "
5. Folic Acid (Vitamin M)FDA LinkGeneric
6. Transcobalamins (Transcobalamin II)IBA
7. Dexamethasone (Maxidex)FDA LinkGeneric
8. Microangiopathic hemolytic anemiaIBA
9. Spermatocidal AgentsIBA
10. Proteins (Proteins, Gene)IBA

Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Transplants (Transplant)
01/01/1999 - "These and future correlated clinical and laboratory assay results may be useful for the development of in utero transplants for a variety of congenital disorders."
01/01/2003 - "The highly orchestrated process of blood cell development and homeostasis is termed "hematopoiesis." Understanding the biology of hematopoietic stem cells as well as hematopoiesis is important to developing improved treatments for hematologic malignancies, congenital disorders, chemotherapy-related cytopenias, and blood and marrow transplants. "
11/01/2002 - "Leukemias, lymphoproliferative disorders, aplastic anemia and congenital disorders of the bone marrow are main indications for allogeneic, lymphoproliferative disorders, leukemias, solid tumors and severe autoimmune disorders main indications for autologous transplants. "
03/01/1997 - "Main indications were leukemias with 4408 transplants (36%), 2977 allogeneic (68%) and 1431 autologous (32%); lymphomas with 4671 transplants (39%), 272 allogeneic (6%) and 4399 autologous (94%); severe aplastic anemia with 237 transplants (2%), 237 allogeneic (100%) and 0 autologous (0%); solid tumors with 2399 transplants (20%), 17 allogeneic (1%) and 2382 autologous (99%); and congenital disorders with 294 transplants (2%), 294 allogeneic (100%) and 0 autologous (0%) and others with 92 transplants (1%), 61 allogeneic (66%) and 31 autologous (34%). "
02/01/1996 - "Main indications in 1994 were leukemias with 3881 transplants (39%), 2635 allogeneic (75%) and 1246 autologous (19%) transplants; lymphomas with 3760 transplants (37%), 245 allogeneic (7%) and 3515 autologous (54%) transplants; severe aplastic anemia with 250 transplants (2%), 248 allogeneic (7%) and 2 autologous transplants; solid tumors with 1800 transplants (18%), 13 allogeneic and 1787 autologous (27%) transplants and congenital disorders with 375 (4%) transplants, 361 allogeneic (11%) and 14 autologous transplants. "
3. Liver Transplantation
4. Drug Therapy (Chemotherapy)
5. Sutures (Suture)